Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis et al. · New England Journal of Medicine · 2004 · 4.6K citations · Full text

Medicine, Cancer Biology, Oncology +16

ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome

Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe‐Jauffret et al. · Cell stem cell · 2007 · 4K citations · Full text

Medicine, Cell Biology, Oncology +14

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

W. Jeffrey Allard, Jeri Matera, Michael Craig Miller et al. · Clinical Cancer Research · 2004 · 2.5K citations

Medicine, Clinical Sciences, Oncology +14

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

Bahriye Aktas, Mitra Tewes, Tanja Fehm et al. · Breast Cancer Research · 2009 · 730 citations · Full text

Medicine, Cancer Biology, Oncology +17

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer

Panayiotis A. Theodoropoulos, Hara Polioudaki, Sofia Agelaki et al. · Cancer Letters · 2009 · 286 citations

Medicine, Cell Biology, Oncology +17